Immortal Dragons, the $40 million longevity-focused innovation fund, today announced its strategic investment in Etheros, a research-driven technology company developing proprietary water-soluble fullerene-based catalytic antioxidant materials. These advanced carbon nanostructure derivatives are designed for use in aging-related scientific research, particularly in the study of oxidative stress and its impact on biological systems. https://mma.prnewswire.com/media/2842136/Immortal_Dragons_1.jpg Growing Global […]

(NASDAQ:DMLP), DALLAS, Dec. 09, 2025 (GLOBE NEWSWIRE) — Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announces the retirement of Mr. William Casey McManemin from the Board of Managers of Dorchester Minerals Management GP LLC, the general partner of the Partnership's general partner (the “Board”), effective December 31, 2025. Mr. McManemin previously led the Partnership as Chief

Dorchester Minerals, L.P. Announces the Retirement of Mr. William Casey McManemin from the Board of Managers; Appointments of Mr. Robert C. Vaughn as Interim Chairman and Mr. Albert G. Nance III to the Board of Managers GlobeNewswire December 09, 2025 DALLAS, Dec. 09, 2025 (GLOBE NEWSWIRE) — Dorchester Minerals, L.P. (the “Partnership”) (NASDAQ-DMLP) announces the

(NYSE:LRN), NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stride, Inc. (NYSE: LRN) between October 22, 2024 and October 28, 2025, both dates inclusive (the “Class Period”), of the important January 12, 2026 lead plaintiff deadline. SO WHAT: If you

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Stride, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LRN GlobeNewswire December 09, 2025 NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Stride, Inc. (NYSE: LRN) between October 22, 2024

(NYSE:HRL), NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hormel Foods Corporation (NYSE: HRL) resulting from allegations that Hormel may have issued materially misleading business information to the investing public. SO WHAT: If

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Hormel Foods Corporation Investors to Inquire About Securities Class Action Investigation – HRL GlobeNewswire December 09, 2025 NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hormel Foods Corporation

In the news release, <CBSA is strengthening the border: 2025 results and accomplishments>, issued <09-Dec-2025> by <Canada Border Services Agency> over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows: CBSA is strengthening the border: 2025 results and accomplishments Canada's Border PlanandBudget 2025 emphasize the importance

(NASDAQ:ADPT), SEATTLE, Dec. 09, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced Dr. Harlan Robins, Chief Scientific Officer and Co-Founder and Susan Bobulsky, Chief Commercial Officer, MRD will

Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease GlobeNewswire December 09, 2025 SEATTLE, Dec. 09, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced